首页> 外文OA文献 >In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes
【2h】

In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes

机译:幼稚脐带血淋巴细胞对巨细胞病毒特异的Th1和Tc1 T细胞的体外引发和扩增

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adoptive transfer of CMV-specific cytotoxic T cells (CTLs) expanded in vitro from memory donor T cells can reduce the incidence of CMV disease in allogeneic transplant recipients. However, this approach has been unavailable in the cord blood (CB) transplantation setting because CB T cells are antigen naive and biased toward Th2/Tc2 function. We developed a protocol to in vitro prime and expand CMV-specific CTLs from CB. T cells were primed with cytokines to trigger skewing toward Th1/Tc1 lineage before encountering monocyte and CD34+ progenitor-derived dendritic cells loaded with CMV antigen and its immune complex. CMV-pulsed cultures expanded significantly more over 4 to 6 weeks than CMV cultures despite identical cytokine milieu. T cells isolated from CMV+ cultures showed a preferential expansion of CD45RA-/RO+/CD27+ T cells compared to CMV- cultures. CMV-specific IFN-γ- and TNF-α-producing CD4+ (Th1) and CD8+ (Tc1) T cells were enriched after 3 to 4 weeks and CMV-specific cytotoxicity developed 1 to 2 weeks later.
机译:在体外从记忆供体T细胞中扩增的CMV特异性细胞毒性T细胞(CTL)的过继转移可以减少同种异体移植受体中CMV疾病的发生率。但是,这种方法在脐带血(CB)移植环境中不可用,因为CB T细胞是幼稚的抗原并且偏向Th2 / Tc2功能。我们开发了从CB在体外引发和扩展CMV特定CTL的协议。在遇到装载有CMV抗原及其免疫复合物的单核细胞和CD34 +祖细胞衍生的树突状细胞之前,先用细胞因子对T细胞进行引发以引发向Th1 / Tc1谱系的偏斜。尽管细胞因子环境相同,但CMV脉冲培养物比CMV培养物在4至6周内扩展得更多。与CMV-培养物相比,从CMV +培养物分离的T细胞显示出CD45RA- / RO + / CD27 + T细胞的优先扩增。产生CMV特异性IFN-γ和TNF-α的CD4 +(Th1)和CD8 +(Tc1)T细胞在3至4周后富集,并在1至2周后出现CMV特异性细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号